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Background: There is no recent data addressing the long term survival of cirrhosis patients without transplantation,
but with the availability of optimal pharmacological and endoscopic therapies. We compared the long term
transplant free survival of alcoholic (AC) and cryptogenic (CC) cirrhosis patients in a setting where liver
transplantation was, until very recently, not available. AC and CC patient details were extracted from our database,
maintained since 1995. For those who had not attended clinics within the past 4 weeks, the patient or families
were contacted to obtain survival status. If deceased, cause of death was ascertained from death certificates and
patient records. Survival was compared using Kaplan-Meier curves.
Results: Complete details were available in 549/651 (84.3%) patients (AC 306, CC 243). Mean follow up duration
(SD) (months) was 29.9 (32.6). 82/96 deaths (85.4%) among AC and 80/94 deaths (85.1%) among CC were liver
related. Multivariate analysis showed age at diagnosis and Child’s class predicted overall survival among all groups.
The median survival in Child’s class B and C were 53.5 and 25.3 months respectively. Survival was similar among AC
and CC. Among AC survival was improved by abstinence [HR = 0.63 (95% CI: 0.40-1.00)] and was worse with
diabetes [HR=1.59 (95% CI: 1.02- 2.48)] irrespective of alcohol status.
Conclusions: The overall survival of AC was similar to CC. Death in both groups were predominantly liver related,
and was predicated by age at diagnosis and Child class. Among AC, presence of diabetes and non-abstinence from
alcohol were independent predictors for poor survival.
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The long term survival of cirrhotic patients is an import-
ant issue in management, from the initial counseling of
the patients at diagnosis to finally planning liver trans-
plantation [1]. This becomes a central issue in settings
where liver transplantation is not readily available. De-
compensated cirrhosis has a dismal prognosis without
transplantation. Although older studies in the pre-
transplantation era have used measures such as the Child-
Pugh score to predict survival [2,3], new pharmacological* Correspondence: hjanakadesilva@gmail.com
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distribution, and reproduction in any mediumand endoscopic therapies have had a significant impact on
improving patient survival [4,5]. As liver transplantation
has becomes a viable option, even in many developing
countries, it has become increasingly difficult to study the
natural history of the disease. Although there have been
published studies of survival in cirrhosis, these have
been on selected populations suitable for transplant or
with single aeitology or with relatively short follow up
periods [6-8]. Although prospective studies are more
valid to assess long term mortality, they would be im-
possible to perform in the current context as liver trans-
plant becomes increasingly available. Therefore even
retrospective data from centers where patients have until
very recently not had the option of liver transplantation,ntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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of cirrhosis with the currently available pharmacological
and endoscopic therapies.
Liver transplantation is in its infancy in Sri Lanka.
Until recently only very few patients with the means of
getting the procedure performed abroad had a liver
transplant. It is still not widely available for most cir-
rhotic patients attending state sector hospitals. This has
provided an opportunity to study the natural history of
the disease in a setting where patients have the benefit
of most modern therapies, with the exception of trans-
plantation. The main causes of cirrhosis in Sri Lanka are
alcohol induced and cryptogenic. The long term com-
parative survival of these two causes of cirrhosis has
been poorly studied especially during the last twenty
years [9-12]. We report our findings where we studied
and compared the long term survival of alcoholic (AC)
and cryptogenic (CC) cirrhosis patients who did not
have the option of liver transplantation.
Methods
The study was conducted in the Gastroenterology Clinic
of the University Medical Unit, Colombo North Tea-
ching Hospital, Ragama, Sri Lanka, which serves as a
major referral center for cirrhosis. Details of all cirrhotic
patients in our clinic have been maintained since 1995.
Study population
All patients diagnosed with AC and CC registered in our
clinic were eligible for inclusion in the study. Cirrhosis
was diagnosed on clinical, biochemical, abdominal ima-
ging, and endoscopic criteria and, when possible or
required, confirmed by liver biopsy. Patients who were
found to have hepatocellular carcinoma at diagnosis
were excluded from the study. AC had a history of con-
suming alcohol above the accepted safe limits (Asian
standards: <14 units alcohol per week in men and <7
units per week alcohol in women) prior to the diagnosis
of cirrhosis. CC were patients who did not drink alcohol
above the safe limit, had no history of contributory drug
or herbal product use and in whom Hepatitis B and C,
autoimmune disease, haemachromatosis, Wilson’s dis-
ease, and alpha-1 antitrypsin deficiency were excluded.
Patients in whom cirrhosis was diagnosed prior to avail-
ability of Hepatitis C testing were subjected to the test
once it became available. Therefore, all patients attend-
ing the clinic had their Hepatitis B and C status assessed
at some time during follow-up.
Study design
This was a retrospective cohort study. Patients diag-
nosed with AC and CC registered in our clinic since
January 1995 were included. This study was conducted
over a period of 4 weeks in June 2010. Patients who hadnot attended the clinic within 4 weeks of the study were
identified, and either the patients or their families were
contacted by telephone or post to obtain survival status,
and if deceased, details of death. The cause of death was
confirmed from death certificates and patient records.
Clinical details of AC and CC were obtained, and
included the date of diagnosis of cirrhosis, liver bio-
chemistry with INR and Child Pugh grade at diagnosis.
Patients with AC and their families were interviewed
for details of alcohol consumption following the diagno-
sis of cirrhosis. ‘Alcohol abstinence’ was defined as
patents who claimed that they never consumed alcohol,
following the diagnosis of cirrhosis. Details of abstinence
were confirmed from family members after consent from
the patient. If the individual patient or the family
claimed that alcohol (of any quantity) was consumed on
one or more occasions following diagnosis of cirrhosis,
the patient was defined as ‘non – abstinent’.
In those whom this information was available, absti-
nence or non-abstinence for alcohol was recorded. The
presence of diabetes anytime during the follow up period
was recorded in all patients.
Ethics approval
Prior ethics approval for this study was obtained from
the Ethics Review Committee of the Faculty of medicine,
University of Kelaniya. Informed consent was taken from
all participating patients and their families regarding
obtaining information as well as follow up data.
Statistical analysis
Unadjusted and adjusted hazard ratios and 95% confi-
dence intervals were estimated using Cox’s proportional
hazards modeling for the association between mortality
and associated factors. Potential confounding variables
considered in the model were age, sex, BMI, diabetes
mellitus, Child-Pugh Grade at diagnosis and the ae-
tiology of cirrhosis (AC or CC). All potential confound-
ing variables were included in the multivariate model.
Survival was compared using Kaplan-Meier curves
using SPSS (version 16.0) and predictors of survival in
each group were sought. The mean and median survival
of cirrhotics was calculated according to Child’s Pugh
class.
Results and discussion
Of the 696 registered cirrhotic patients, AC and CC
accounted for 651 (93.53%) (Table 1). The numbers of
patients having cirrhosis due to other aetiologies were
considered too small to study their natural history. Fur-
thermore, the possibility of at least some patients
defined as CC being surreptitious drinkers, and therefore
in reality being AC should be considered when interpret-
ing these data.
Table 1 Aetiology of cirrhosis in database
Aetiology Number Percentage
Alcohol (AC) 381 54.74%
Cryptogenic (CC) 270 38.79%
Hepatitis B 13 1.87%
Wilson’s disease 13 1.87%
Autoimmune 7 1.01%
Drug induced 4 0.57%
Hepatitis C 3 0.43%
Haemochromatosis 3 0.43%
PBC 1 0.14%
Traditional and herbal medicines 1 0.14%
Total 696 100.00%
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were available for analysis in 549 (84.3%) (AC 306, CC
243). Demographic and clinical characteristics in these
patients are given in Table 2. Type 2 diabetes or obesity
was present in 68.7% of patients with CC. Details of AC
and CC with and without follow up data are given in
Table 3.
Deaths among both AC and CC were predominantly
liver related (85.3%). There were 96 deaths [82 (85.4%)Table 2 Selected demographic, clinical data and deaths amon
Alcoholic Cirrhosis (n=306)
Mean age (SD) at diagnosis (years) 52.5 (9.7)
Sex Male :299
Female :7
Child class at diagnosis A :74 (24.18%)
B :159 (51.96%)
C :73 (23.86%)
Serum Bilirubin (SD) 3.3 (3.6)
Serum Albumin (SD) 29.8 (7.3)
Mean follow up duration (SD) (months) 29.25 (32.52)
No. with diabetes(Dm) 125(40.85%)
No. with obesity(BMI>=25) 68(22.22%)











Total deaths 96(100%)liver related] in the AC group and 94 deaths [80
(85.1%) liver related] in the CC group (Table 2). Among
the patients with liver related deaths, causes of death
were hepatic encephalopathy (37.2%), upper GI bleeding
(32.6%), hepato-renal syndrome (18.6%), development of
hepatocellular carcinoma in (9.3%) and spontaneous
bacterial peritonitis in (2.3%).
The overall median survival of patients in Child’s class
B and C were 53.5 and 25.3 months respectively
(Table 4). The duration of follow up of patients with
Child’s class A cirrhosis was inadequate to assess the
median survival in this group. The median survival of
AC and CC were 66.9 and 46.2 months respectively.
However, Kaplan-Meier survival curves showed no sig-
nificant difference in survival between AC and CC (log
rank test statistic 0.297) (Figure 1).
Among the 306 patients with AC 198 (64.7%) volun-
teerd information regarding alcohol consumption after
diagnosis. For deceased patients this information was
obtained from the family members. The percentage of
AC claming to be abstinent was 75.8%. Among AC
claiming abstinence (n=150), 50 patients (33.3%) had
died during follow up. Among AC who were not abstain-
ing (n=48), 30 (62.5%) had died. The survival of AC who
continued to drink, AC who claimed abstinence and CCg study population
Cryptogenic Cirrhosis (n=243) Total (n=549)
58.4 (10.6) 55.1 (10.5)
Male :135 Male :434
Female :108 Female :115
A :87 (35.80%) A :161 (29.33%)
B :125 (51.44%) B :284 (51.73%)
C :31 (12.76%) C :104 (18.94%)
2.3 (1.9) 2.9 (3.0)
32.7 (9.0) 31.1 (8.2)
30.76 (32.83) 29.92 (32.64)
128(52.67%) 253(46.08%)
71(29.22%) 139(25.32%)
Dm only:96(39.51%) Dm only:197(35.88%)









Table 3 Details of demographic and clinical characteristics among AC and CC with and without follow up data
Follow up data available (n=549) Follow up data not available (n=102)
Mean age (SD) at diagnosis (years) 55.1 (10.5) 52.2 (14.6)
Sex Male :434 Male : 92
Female :115 Female :10
AC 306 64
CC 243 38
Child class at diagnosis A :161 (29.33%) A :36 (35.29%)
B :284 (51.73%) B : 40 (39.22%)
C :104 (18.94%) C : 26 (25.49%)
No. with diabetes (Dm) 253(46.08%) 35 (34.31%)
No. with obesity (BMI>=25) 139(25.32%) 28 (24.51%)
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Meier survival curves using the log rank test, among AC,
those who were not abstaining had a worse survival com-
pared to AC claiming abstinence (p=0.048). Compared
to CC (median survival 46.2 months), there was a trend
for better survival among AC who claimed abstinence
(median survival 61.9 months), however this difference
was not statistically significant (p=0.476) (Figure 2).
However, this data may be confounded by immortal
time bias. In an attempt to overcome this we re-
analysed the effects of abstinence by categorizing AC
patients only according to whether they were consum-
ing alcohol at the time of diagnosis of cirrhosis. The
survival patterns of a sub-sample of AC who were con-
tinuing to drink at the time of diagnosis (n=39), AC
who claimed abstinence at the time of diagnosis and CC
did not change significantly from our initial analysis
(Figure 3). On comparison of Kaplan Meier survival
curves using the log rank test, among AC, those who
were not abstaining had a worse survival compared to
AC claiming abstinence. Compared to CC (median sur-
vival 46.2 months), there was a trend for better survival
among AC who claimed abstinence (median survival
66.9 months), although this difference was not statisti-
cally significant.
Kaplan-Meier survival curves showed a significant dif-
ference in survival between AC who did not have diabetes
and those who had diabetes, with the latter having a
worse prognosis (Log rank test statistic 0.024) (Figure 4).Table 4 Median survival of patients by Child’s grade





(log rank test statistic <0.001).This difference persisted among AC claiming abstinance,
with and without diabetes (Log rank test statistic 0.039).
This adverse effect of diabetes on survival was not seen
among CC (p= 0.21).
On bivariate analysis, factors associated with mortal-
ity were, age at diagnosis and Child’s class (Table 5).
On multivariate analysis independent predictors of
mortality were: age at diagnosis and Child’s class after
adjusting for sex, BMI, diabetes mellitus and aetiology
of cirrhosis (AC or CC). Each year of age increased the
risk of mortality by 1.03 times. A patient in Child’s
class B had a 3 times higher risk of mortality as com-
pared to a patient in Child’s class A. A patient in
Child’s class C had a 7 times higher risk of mortality as
compared to a patient in Child’s class A (Table 4).
Kaplan-Meier survival curves for different Child’s
classes among AC and CC are shown in Figure 5 and
Figure 6 respectively.
Among AC survival was improved by abstinence [HR =
0.63 (95% CI: 0.40-1.00)] and was worse in the presence
of diabetes [HR=1.59 (95% CI: 1.02- 2.48)].
In our sample, none of the patients had the option of
being listed for liver transplantation as this was not
available in Sri Lanka at the time of the study, and none
of the study population could afford transplantation
abroad. Despite this, they were all provided with optimal
pharmacological and endoscopic therapy. This provided
an unique opportunity for us to study true transplant
free survival in the current context.Median survival (months) 95% CI
- -
53.5 31.4– 75.7
25.3 15.6 – 35.0
55.1 41.0 - 69.1
Figure 1 Comparison of long term survival - Alcoholic cirrhosis (AC) vs Cryptogenic cirrhosis(CC).
Figure 2 Comparison of long term survival – AC continuing alcohol vs AC claiming abstinence vs CC.
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Figure 3 Comparison of long term survival – AC continuing alcohol at the time of diagnosis vs AC claiming abstinence at the time of
diagnosis vs CC.
Figure 4 Comparison of long term survival – AC with diabetes vs AC without diabetes.
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Table 5 Factors associated with death in patients with cirrhosis
Variable Dead (n=190) Alive (n=359) HR (95% CI) (bivariate analysis
without adjusting for any variable)
HR (95% CI) (multivariate analysis
adjusting for all variables)
Age (considered as
a continuous variable)
1.02 (1.01-1.04)* 1.03 (1.01-1.04)*
BMI (considered as
a continuous variable)
0.98 (0.94-1.03) 0.99 (0.96-1.04)
Male sex (%) 145 (76.3) 289 (80.5) 0.81 (0.58-1.13) 0.77 (0.48-1.25)
Child class A** 26 (13.7) 135 (37.6) - -
Child class B 107 (56.3) 177 (49.3) 2.83 (1.84-4.35)* 3.17 (1.85-5.46)*
Child class 3 57 (30.0) 47 (13.1) 6.21 (3.89-9.83)* 7.07 (3.94-12.68)*
Alcoholic cirrhosis (%) 96 (50.5) 210 (58.5) 0.86 (0.65-1.14) 0.79 (0.52-1.20)




95% CI-95% confidence interval.
Senanayake et al. BMC Research Notes 2012, 5:663 Page 7 of 10
http://www.biomedcentral.com/1756-0500/5/663Previous studies on the natural history of patients in
settings where transplantation is available are fundamen-
tally different from our study for several reasons. Firstly,
patient populations of those studies comprised only of
patients who qualified for a liver transplant [6,7]. Sec-
ondly, they were followed up for relatively shorter time
periods [7]. Finally, the use of Kaplan –Meier survival
curves is suboptimal in that situation as multiple out-
comes which affect one another, namely, transplantation
and death, have to be considered [6]. Kim et al. uses
“competing risk analyses” as an alternative method of
analysis, but admits that “Kaplan-Meier estimates may
be the most appropriate to answer certain ‘what if ’ ques-
tions, for example, when counseling a patient about theirFigure 5 Comparison of long term survival among alcoholic cirrhoticsfuture course without transplantation” [6]. This is what
our study hoped to address.
Our results indicate that the median overall survival of
Child’s B and C cirrhotics was 53.5 months and 25.3
months respectively. This is in contrast to older esti-
mates [3] which suggested a much shorter survival with-
out liver transplantation. This may reflect better
pharmacotherapy and endotherapy which is currently
available altering the natural history of the disease [4,5].
This hypothesis needs further investigation.
There was a relatively short mean follow period up of
29.9 months for this study. The reason for this is that as
our centre became established as a national referral
centre for liver diseases the number of patients referred(AC) according to Child class at diagnosis.
Figure 6 Comparison of long term survival among cryptogenic cirrhotics (CC) according to Child class at diagnosis.
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initial stages.
We found that the survival of patients with AC and
CC was similar. The survival of these two groups has
been poorly compared during the last twenty years.
Stone et al. in 1968 reported that AC appeared to have a
better outlook than CC [10]. Later, in 1987, Tanaka et al.
reported that survival of AC was poorer than CC [12].
The investigators also reported that survival of both
types of cirrhosis improved over the three decades of
study (1958–1984) [12]. Our finding of a similar survival
for both AC and CC possibly reflects overall improve-
ment in the care of severely ill cirrhotic patients. In
addition, the relatively high percentage of AC abstaining
from alcohol (75.8%) in our sample, if reliable, may also
have contributed to a better prognosis. The majority of
deaths among AC and CC were liver related (85.3%).
This is similar to earlier reports where Tanaka et al.
reported non-liver related causes of death to be 8% [12].
We found, predictably, that abstinence from alcohol
significantly improves long term survival among AC.
This has been established in previous studies [11-15].
This emphasizes the importance of reinforcing alcohol
abstinence in the management of these patients.
Numerous studies have reported a high prevalence of
obesity and diabetes among patient with CC and sug-
gested that most of these patients represent non alco-
holic steatohepatitis (NASH) related cirrhosis [16-18]. It
has been suggested that in Asia many cases of CC may
be related to non alcoholic fatty liver disease [19]. Over
two thirds of our patients with CC (68.7%) had diabetesor obesity. Such a high prevalence of metabolic risk fac-
tors may not be surprising among South Asian popula-
tions [20,21]. However this high percentage of patients
with metabolic risk factors (diabetes or obesity) among
our patients diagnosed with CC suggests that the likely
aetiology of their ‘cryptogenic’ cirrhosis is non- alcoholic
steatohepatitis (NASH).
In our study, diabetes was found to be an independ-
ent predictor of mortality among AC, but not among
CC. Diabetes may be an aggravating factor in the evo-
lution of cirrhosis or may occur as a consequence of
cirrhosis - termed “hepatogenous diabetes” [22,23]. Al-
though the available data is limited, it had been sug-
gested that diabetes is associated with a worse
prognosis in cirrhosis [24-26] and that impaired oral
glucose tolerance may predict long term [27] as well as
the short term mortality [28] among cirrhotics. How-
ever, Chen et al. recently reported no association be-
tween diabetes and the in–hospital mortality of
cirrhosis patients, although they too found that a sig-
nificant proportion of cirrhotic patients had diabetes
[29]. The association between cirrhosis and diabetes,
especially in relation to different aetiologies of cirrhosis,
warrants further investigation. We found that diabetes
continues to be a predictor of mortality even among
AC who abstain from alcohol. Moreau et al. also
reported a similar association between diabetes, abstin-
ence and mortality among cirrhotics who had refractory
ascites [25].
Demographically, the two groups of patients in our
study were similar except that there were far fewer
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drinking habits in an average Sri Lankan population
where, for possible cultural reasons, heavy alcohol con-
sumption among females is very uncommon. However
sex was not a significant predictor of survival when
other factors (Child’s class, alcohol abstinence, presence
of diabetes, obesity and the etiology of cirrhosis etc.)
were adjusted for, and hence did not seem to affect sur-
vival in these two groups.
Among co-morbidities only diabetes and obesity were
assessed as predictors of survival. Socio-economic status
as a predictor of outcome was not assessed in this study.
These are limitations of our study.
We assessed survival of our patients according to the
Child-Pugh class. Assessing survival according to their
MELD score would have been advantageous. The MELD
score only came into wide use in 2002, when it was
adopted as the criteria by which donor organs are dis-
tributed by UNOS (United Network for Organ Sharing)
[6,30]. Our patients were followed up since 1995, and
the MELD score at first presentation had not been cal-
culated in a large proportion of our patients. However,
Child Pugh class is still routinely used in clinical practice
as a useful bedside assessment of patient prognosis and
has been shown to be of similar prognostic value to
MELD in some studies [31].
Ours was a retrospective study. A prospective study
such as this would not have been possible in the current
context because liver transplantation has commenced in
our center in Sri Lanka.
We were able to contact 84.3% of the total registered
population of cirrhotic patients. This represents the diffi-
culties encountered during long term follow up of
patients in a setting where hospitals and death registries
are not linked electronically. In many cases, changes in
addresses and phone numbers limited our ability to con-
tact patients. Follow up of a large number of alcoholic
cirrhotic patients whose compliance with clinic attend-
ance is usually erratic is bound to be difficult in any
setting.
Conclusions
In a setting where liver transplantation is not readily
available, we found that the overall survival of AC was
similar to CC. Death in both groups were predominantly
liver related, and was predicated by age at diagnosis and
Child Pugh class, although survival was longer than that
suggested in older studies. This may reflect better
pharmacotherapy and endotherapy which is currently
available altering the natural history of the disease.
Among AC, those who continued to drink had the worst
survival, and the presence of diabetes and non-
abstinence from alcohol were independent predictors of
mortality.Abbreviations
AC: Alcoholic cirrhosis; CC: Cryptogenic cirrhosis; MELD: Model For End-Stage
Liver Disease.
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